Melanie Comito, MD

INCB 18424-269 (COG AALL1521), A Phase 2 Study of the JAK1/JAK2 Inhibitor Ruxolitinib With Chemotherapy in Children With De Novo High-Risk CRLF2 Rearranged and/or JAK Pathway–Mutant Acute Lymphoblastic Leukemia
Read more

International Registry for Severe Chronic Neutropenia
Read more

Protocol for the Enrollment on the Official COG Registry, The Childhood Cancer Research Network (CCRN)
Read more

Neuropsychological, Social, Emotional and Behavioral Outcomes in Children with Cancer
Read more

Umbrella Long-Term Follow-Up Protocol
Read more

Key Adverse Events Following Childhood Cancer
Read more

4941L: National Wilms Tumor Late Effects Study
Read more

Treatment for Patients with Bilateral, Multicentric, or Bilaterally-Predisposed Unilateral Wilms Tumor: A Groupwide Phase III Study
Read more

Renal Tumors Classification, Biology and Banking Study
Read more

A Randomized Phase II study of Brentuximab Vedotin (NSC# 749710) and Crizotinib (NSC# 749005) in Patients with Newly Diagnosed Anaplastic Large Cell Lymphoma
Read more

Intergroup Trial for Children or Adolescents with B-cell Non-Hodgkin Lymphoma NHL or Mature B-cell Leukemia B- AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients.
Read more

Rare and Cutaneous Non-Hodgkin Lymphoma Registry
Read more

Pilot Study Using Myeloablative Busulfan/Melphalan (BuMel) Consolidation Following Induction Chemotherapy for Patients with Newly Diagnosed High-Risk Neuroblastoma
Read more

Neuroblastoma Biology Studies
Read more

Phase III Randomized Study of Chimeric Antibody 14.18 (Ch14.18) in High Risk Neuroblastoma Following Myeloablative Therapy and Autologous Stem Cell Rescue
Read more

Treatment of Children with All Stages of Hepatoblastoma
Read more

A Children's Oncology Group Protocol for Collecting and Banking Osteosarcoma Specimens
Read more

A COG Soft Tissue Sarcoma Diagnosis, Biology and Banking Protocol
Read more

A Phase III Randomized Trial of Adding Vincristine-topotecan-cyclophosphamide to Standard Chermotherapy in Initial Treatment of non-metastatic Ewing Sarcoma
Read more

A Children's Oncology Group Protocol for Collecting and Banking Ewing Sarcoma Specimens
Read more

Phase II Trial of Response-Based Radiation Therapy for Patients with Localized Central Nervous System Germ Cell Tumors (CNS GCT): A Groupwide Phase II Study
Read more

A Phase II Randomized Trial of Lenalidomide (NSC # 703813, IND # 70116) in Pediatric Patients with Recurrent, Refractory or Progressive Juvenile Pilocytic Astrocytoma and Optic Pathway Gliomas
Read more

Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 years
Read more

Temozolomide with Irinotecan versus Temozolomide, Irinotecan plus Bevacizumab for Recurrent/Refractory Medulloblastoma/CNS PNET of Childhood, A COG Randomized Phase II Screening Trial
Read more

A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND#114480; NSC# 681239, NSC# 724772) for Patients with High Allelic Ratio FLT3/ITD
Read more

Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome (DS)
Read more

A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk Stratum
Read more

(CA180372) A Phase II Multi-Center, Historically-Controlled Study of Dasatinib Added to Standard Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Read more

Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL): A Groupwide Phase III Study
Read more

Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
Read more

A study of neurocognitive function in children treated for ALL
Read more

A Phase III Study of Risk Directed Therapy for Infants with Acute Lymphoblastic Leukemia (ALL): Randomization of Highest Risk Infants to Intensive Chemotherapy +/- FLT3 Inhibition
Read more

A Children's Oncology Group Protocol for Collecting and Banking Relapsed Acute Lymphoblastic Leukemia Research Specimens
Read more

Intensified Methotrexate, Nelarabine (Compound 506U78; IND# 52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia
Read more